{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T02:43:02Z","timestamp":1792896182935,"version":"4.5.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T00:00:00Z","timestamp":1733097600000},"content-version":"vor","delay-in-days":1,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Saudi Dental Journal"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.sdentj.2024.12.005","type":"journal-article","created":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T22:14:31Z","timestamp":1733436871000},"page":"1635-1640","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Antiresorptive medication-related osteonecrosis of the jaw: Incidence and preventive measures utilization in cancer patients"],"prefix":"10.1007","volume":"36","author":[{"given":"Salman Ali","family":"Alabdali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulrahman Ali","family":"Alabdali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sultan Qais","family":"Alnoaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Abuasida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saud","family":"Balelah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulaziz","family":"Almuzaini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah Homeed","family":"Almatrafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein M.","family":"Elbadawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"10.1016\/j.sdentj.2024.12.005_b0005","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.3390\/ijms18061261","article-title":"Enhanced osteogenic differentiation in zoledronate-treated osteoporotic patients","volume":"18","author":"Carbonare","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.sdentj.2024.12.005_b0010","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1007\/s11914-018-0474-4","article-title":"Current understanding of the pathophysiology of osteonecrosis of the jaw","volume":"16","author":"Chang","year":"2018","journal-title":"Curr. Osteoporos. Rep."},{"key":"10.1016\/j.sdentj.2024.12.005_b0015","doi-asserted-by":"crossref","first-page":"3747","DOI":"10.3390\/jcm12113747","article-title":"Risk factors for medication-related osteonecrosis of the jaw\u2014a binomial analysis of data of cancer patients from craiova and constanta treated with zoledronic acid","volume":"12","author":"Ciobanu","year":"2023","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.sdentj.2024.12.005_b0020","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.enfcle.2017.04.008","article-title":"Intervention to improve awareness of the risk factors for osteonecrosis of the jaw in patients under treatment with bisphosponates. Randomised clinical trial","volume":"27","author":"Garc\u00eda-Mart\u00ednez","year":"2017","journal-title":"Enfermer\u00eda Cl\u00ednica (English Edition)"},{"key":"10.1016\/j.sdentj.2024.12.005_b0025","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1200\/JCO.2010.31.3304","article-title":"Randomized, double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma","volume":"29","author":"Henry","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.sdentj.2024.12.005_b0030","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.amjmed.2008.01.047","article-title":"Factors associated with osteonecrosis of the jaw among bisphosphonate users","volume":"121","author":"Hess","year":"2008","journal-title":"Am. J. Med."},{"key":"10.1016\/j.sdentj.2024.12.005_b0035","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1248\/bpb.b15-00385","article-title":"Incidence and risk factors of osteonecrosis of the jaw in advanced cancer patients after treatment with zoledronic acid or denosumab: a retrospective cohort study","volume":"38","author":"Kajizono","year":"2015","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.sdentj.2024.12.005_b0040","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.oraloncology.2018.08.003","article-title":"Risk-reductive dental strategies for medication related osteonecrosis of the jaw among cancer patients: A systematic review with meta-analyses","volume":"85","author":"Karna","year":"2018","journal-title":"Oral Oncol."},{"key":"10.1016\/j.sdentj.2024.12.005_b0045","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jbmr.2405","article-title":"Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus","volume":"30","author":"Khan","year":"2015","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.sdentj.2024.12.005_b0050","series-title":"Bisphosphonate\u2010associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research","first-page":"1479","author":"Khosla","year":"2007"},{"key":"10.1016\/j.sdentj.2024.12.005_b0055","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.3390\/ijms20061467","article-title":"Zoledronate enhances osteocyte-mediated osteoclast differentiation by IL-6\/RANKL axis","volume":"20","author":"Kim","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.sdentj.2024.12.005_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2020.115650","article-title":"Incidence of and risk for osteonecrosis of the jaw in Korean osteoporosis patients treated with bisphosphonates: A nationwide cohort-study","volume":"143","author":"Kim","year":"2021","journal-title":"Bone"},{"key":"10.1016\/j.sdentj.2024.12.005_b0065","doi-asserted-by":"crossref","first-page":"4634","DOI":"10.1200\/JCO.2008.16.2768","article-title":"Bisphosphonate-related osteonecrosis of the jaws: a case-control study of risk factors in breast cancer patients","volume":"26","author":"Kyrgidis","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.sdentj.2024.12.005_b0070","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1016\/j.joms.2007.08.003","article-title":"Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment","volume":"65","author":"Marx","year":"2007","journal-title":"J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.sdentj.2024.12.005_b0075","doi-asserted-by":"crossref","first-page":"6429","DOI":"10.1007\/s00520-022-06940-8","article-title":"The preventive care of medication-related osteonecrosis of the jaw (MRONJ): a position paper by Italian experts for dental hygienists","volume":"30","author":"Mauceri","year":"2022","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.sdentj.2024.12.005_b0080","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/odi.12708","article-title":"Risk factors for medication\u2010related osteonecrosis of the jaws: A systematic review","volume":"24","author":"McGowan","year":"2018","journal-title":"Oral Dis."},{"key":"10.1016\/j.sdentj.2024.12.005_b0085","doi-asserted-by":"crossref","first-page":"7948","DOI":"10.3390\/ijms24097948","article-title":"Immune dysfunction in medication-related osteonecrosis of the jaw","volume":"24","author":"Roato","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.sdentj.2024.12.005_b0090","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.joms.2022.02.008","article-title":"American Association of Oral and Maxillofacial Surgeons\u2019 position paper on medication-related osteonecrosis of the jaws\u20142022 update","volume":"80","author":"Ruggiero","year":"2022","journal-title":"J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.sdentj.2024.12.005_b0095","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1200\/jop.2006.2.1.7","article-title":"Practical guidelines for the prevention, diagnosis, and treatment of osteonecrosis of the jaw in patients with cancer","volume":"2","author":"Ruggiero","year":"2006","journal-title":"J. Oncol. Pract."},{"key":"10.1016\/j.sdentj.2024.12.005_b0100","unstructured":"SFDA, Saudi Food and Drug Administration. 2023. \u201cEducational Card on Osteonecrosis of the Jaw (ONJ).\u201d In SFDA website. https:\/\/www.sfda.gov.sa\/en\/: Saudi Food and Drug Administration."},{"key":"10.1016\/j.sdentj.2024.12.005_b0105","doi-asserted-by":"crossref","unstructured":"Toole, Jamie. 2015. \u201cOsteonecrosis of the jaws.\u201d In, 1755-56. Rheumatology: Oxford University Press.","DOI":"10.1093\/rheumatology\/kev094"},{"key":"10.1016\/j.sdentj.2024.12.005_b0110","article-title":"The role of the immune response in the development of medication-related osteonecrosis of the jaw","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Immunol."}],"container-title":["The Saudi Dental Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1013905224003225?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1013905224003225?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T17:21:36Z","timestamp":1736184096000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1013905224003225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":22,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S1013905224003225"],"URL":"https:\/\/doi.org\/10.1016\/j.sdentj.2024.12.005","relation":{},"ISSN":["1013-9052"],"issn-type":[{"value":"1013-9052","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiresorptive medication-related osteonecrosis of the jaw: Incidence and preventive measures utilization in cancer patients","name":"articletitle","label":"Article Title"},{"value":"The Saudi Dental Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sdentj.2024.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 THE AUTHORS. Published by Elsevier B.V. on behalf of King Saud University.","name":"copyright","label":"Copyright"}]}}